ADRIANA DISTANISLAO: Open Payments
NPI 1497181416 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 40 payments from 15 companies in 2025. Trend: 2023 $985 · 2024 $808 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $166 |
| UCB, Inc. | 4 | $108 |
| Janssen Biotech, Inc. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| GENZYME CORPORATION | 1 | $43 |
| Amgen Inc. | 2 | $37 |
| Incyte Corporation | 1 | $29 |
| Galderma Laboratories, L.P. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
Products named: Bimzelx, SKYRIZI, TREMFYA, RINVOQ, COSENTYX, Sotyktu, DUPIXENT, Otezla.
Industry payments across PA — which companies pay providers there.
